Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001640334-25-001321
Filing Date
2025-07-25
Accepted
2025-07-25 16:10:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9384
  Complete submission text file 0001640334-25-001321.txt   11375
Mailing Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000
Business Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000 86 (010) 6615-5141
Yubo International Biotech Ltd (Subject) CIK: 0000895464 (see all company filings)

EIN.: 113074326 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-52079 | Film No.: 251151785
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O YUBO INTERNATIONAL BIOTECH LIMITED ROOM 105, BUILDING 5, 31 XISHIKU AVENUE XICHENG DISTRICT, BEIJING F4 00000
Business Address C/O YUBO INTERNATIONAL BIOTECH LIMITED ROOM 105, BUILDING 5, 31 XISHIKU AVENUE XICHENG DISTRICT, BEIJING F4 00000 86 010 6615 5141
Flydragon International Ltd (Filed by) CIK: 0001841458 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A